These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32934294)

  • 1. Elucidating potential molecular signatures through host-microbe interactions for reactive arthritis and inflammatory bowel disease using combinatorial approach.
    Verma A; Sharda S; Rathi B; Somvanshi P; Pandey BD
    Sci Rep; 2020 Sep; 10(1):15131. PubMed ID: 32934294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis.
    Fendler C; Laitko S; Sörensen H; Gripenberg-Lerche C; Groh A; Uksila J; Granfors K; Braun J; Sieper J
    Ann Rheum Dis; 2001 Apr; 60(4):337-43. PubMed ID: 11247862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota as Therapeutic Targets.
    Xavier RJ
    Dig Dis; 2016; 34(5):558-65. PubMed ID: 27331403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbial co-abundance networks show specificity in inflammatory bowel disease and obesity.
    Chen L; Collij V; Jaeger M; van den Munckhof ICL; Vich Vila A; Kurilshikov A; Gacesa R; Sinha T; Oosting M; Joosten LAB; Rutten JHW; Riksen NP; Xavier RJ; Kuipers F; Wijmenga C; Zhernakova A; Netea MG; Weersma RK; Fu J
    Nat Commun; 2020 Aug; 11(1):4018. PubMed ID: 32782301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial and genetic-based framework identifies drug targets in inflammatory bowel disease.
    Wang Z; Guo K; Gao P; Pu Q; Lin P; Qin S; Xie N; Hur J; Li C; Huang C; Wu M
    Theranostics; 2021; 11(15):7491-7506. PubMed ID: 34158863
    [No Abstract]   [Full Text] [Related]  

  • 6. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
    Lee M; Chang EB
    Gastroenterology; 2021 Jan; 160(2):524-537. PubMed ID: 33253681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota Perturbations in Reactive Arthritis and Postinfectious Spondyloarthritis.
    Manasson J; Shen N; Garcia Ferrer HR; Ubeda C; Iraheta I; Heguy A; Von Feldt JM; Espinoza LR; Garcia Kutzbach A; Segal LN; Ogdie A; Clemente JC; Scher JU
    Arthritis Rheumatol; 2018 Feb; 70(2):242-254. PubMed ID: 29073348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
    Sitkin SI; Tkachenko EI; Vakhitov TY
    Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota and Alimentary Tract Injury.
    Chen Y; Wu G; Zhao Y
    Adv Exp Med Biol; 2020; 1238():11-22. PubMed ID: 32323177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles produced by the human commensal gut bacterium Bacteroides thetaiotaomicron affect host immune pathways in a cell-type specific manner that are altered in inflammatory bowel disease.
    Gul L; Modos D; Fonseca S; Madgwick M; Thomas JP; Sudhakar P; Booth C; Stentz R; Carding SR; Korcsmaros T
    J Extracell Vesicles; 2022 Jan; 11(1):e12189. PubMed ID: 35064769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease.
    Iyer N; Corr SC
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease.
    Heinken A; Ravcheev DA; Baldini F; Heirendt L; Fleming RMT; Thiele I
    Microbiome; 2019 May; 7(1):75. PubMed ID: 31092280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host Genetic and Gut Microbial Signatures in Familial Inflammatory Bowel Disease.
    Park YM; Ha E; Gu KN; Shin GY; Lee CK; Kim K; Kim HJ
    Clin Transl Gastroenterol; 2020 Jul; 11(7):e00213. PubMed ID: 32764209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chlamydia-associated arthritis and enteropathic arthritis--two important spondyloarthritides].
    Kotake S; Nanke Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(3):121-30. PubMed ID: 21720100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
    Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
    Lin L; Zhang J
    BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the host-microbe interactions using metabolic modeling.
    Jansma J; El Aidy S
    Microbiome; 2021 Jan; 9(1):16. PubMed ID: 33472685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
    Aldars-García L; Marin AC; Chaparro M; Gisbert JP
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.